The cardiac beta-adrenergic system is transiently enhanced during early diabetes in a hamster model, preceding the development of cardiac hypertrophy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for early sympathetic changes in diabetic cardiomyopathy; human studies needed before clinical relevance.
Serial changes in cardiac norepinephrine content and the beta-adrenergic system were investigated during the development of cardiomyopathy in spontaneously diabetic Chinese hamsters (CHAD strain), in comparison to age-matched control Chinese hamsters (CHA) or non-diabetic CHAD hamster littermates. Cardiac norepinephrine content and beta-adrenergic receptor density significantly increased in short-term diabetics. These changes preceded both the development of cardiac hypertrophy and the enhanced response of adenylyl cyclase to isoproterenol plus 5'-guanylylimidodiphosphate [Gpp (NH)p], sodium fluoride, or forskolin stimulation. However, as the diabetic state developed cardiac norepinephrine content, beta-adrenergic receptor density, and adenylyl cyclase activity returned to control levels. The amount of stimulatory or inhibitory guanine nucleotide binding proteins in the diabetic group was similar to those in the control groups. These data suggest that the cardiac beta-adrenergic system is enhanced by the alterations in cardiac sympathetic activity during early diabetes, which are associated with the duration of diabetes rather than with the degree of hypertrophy or strain differences.
No takes yet. Share an insight, caveat, or question.
Uekita et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: